Insmed (INSM) Net Cash Flow (2010 - 2026)

Insmed's Net Cash Flow history runs 17 years deep, the most recent figure standing at $72.3 million for Q1 2026.

• On a quarterly basis, Net Cash Flow rose 147.35% year-over-year to $72.3 million in Q1 2026; TTM through Mar 2026 was $179.5 million, a 192.97% increase from a year earlier, with the FY2025 full-year figure at -$45.5 million, down 161.54% from the prior year.
• Net Cash Flow fell to $72.3 million in Q1 2026 per INSM's latest filing, from $175.7 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $880.1 million in Q2 2025 and bottomed at -$948.6 million in Q3 2025.
• The 5-year median for Net Cash Flow is -$5.8 million (2023), against an average of -$7.8 million.
• Across the five-year window, Net Cash Flow tumbled 3783.94% in 2023 and soared 1752.77% in 2024, its largest moves.
• Year by year, Net Cash Flow stood at $660.5 million in 2022, then plunged by 100.87% to -$5.8 million in 2023, then surged by 1752.77% to $95.1 million in 2024, then soared by 84.76% to $175.7 million in 2025, then plunged by 58.85% to $72.3 million in 2026.
• Per Business Quant, the three latest INSM Net Cash Flow figures stand at $72.3 million (Q1 2026), $175.7 million (Q4 2025), and -$948.6 million (Q3 2025).